Cancer and bacterial infections are estimated to kill 18 million people worldwide each year by 2050. Fast and reliable diagnostics are essential for early and targeted treatments. Microfluidics is an emerging technology where tiny samples of liquids or biological fluids (blood or urine) are processed and analysed.
By taking part to this project you will become part of a large consortium of 8 partners including SMEs in the renewable technologies, leading EU research institutions and NGOs.
